How a lung-specific factor influences T cells in allergic asthma

Lung-specific expression and function of Blimp-1 in T cells impacting allergic asthma

NIH-funded research University of Pittsburgh at Pittsburgh · NIH-11061805

This study is looking at a protein called Blimp-1 in T cells to see how it affects allergic asthma, helping us understand how it contributes to lung inflammation when you're exposed to allergens.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-11061805 on NIH RePORTER

What this research studies

This research investigates the role of a protein called Blimp-1 in T cells and its impact on allergic asthma. It focuses on understanding how Blimp-1 contributes to the development of T cells that drive inflammation in the lungs when exposed to allergens. The researchers will explore the specific environment in the lungs that promotes Blimp-1 expression and how this leads to chronic inflammation. By examining the pathways involved, they aim to uncover new insights into the mechanisms of allergic asthma.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with allergic asthma, particularly those experiencing chronic symptoms related to allergen exposure.

Not a fit: Patients with non-allergic asthma or those whose asthma is not influenced by T cell responses may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better manage or prevent allergic asthma by targeting the pathways involving Blimp-1.

How similar studies have performed: While the role of Blimp-1 in T cell regulation is being explored, this specific focus on its lung-specific expression in allergic asthma is relatively novel and has not been extensively tested.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Allergic Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.